Trump Plan to Curb Drug Prices Targets Rebates to Pharmacy Benefit Managers

The Trump administration proposed ending a complex system of drug rebates that influence tens of billions of dollars in U.S. pharmaceutical spending, a move that could upend the relationship between drugmakers and pharmacy benefits middlemen. The proposal, a long-awaited part …

from News – Insurance Journal http://bit.ly/2S3vedq